CD79A and infection: Interestingly, the ability of ibrutinib administration to improve serum IgA levels – with an observed lower rate of infections in patients showing greater improvements in IgA – further confirmed the role of IgA as both an active weapon against infections and an indicator of improved immune functionality [94].